ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

2 years ago

PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™,…

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

2 years ago

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators Einstein A young and Handsome Albert Einstein MIAMI, March…

Psyence Biomedical Ltd. Receives Nasdaq Notifications Regarding Market Value of Listed Securities and Market Value of Publicly Held Shares

2 years ago

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (the “Company”) (Nasdaq: PBM) announced that on March 11,…

NurExone’s Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence

2 years ago

TORONTO and HAIFA, Israel, March 15, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or…

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

2 years ago

SAN JOSE, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a…

XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps

2 years ago

ReOpen was the first ever large placebo-controlled clinical trial program to demonstrate statistically significant reduction of symptoms in chronic sinusitis…

Sanofi: Information concerning the total number of voting rights and shares – February 2024

2 years ago

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…

Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.

2 years ago

The certification has the potential to open access to Islamic markets globally, expanding potential markets for Scilex’s innovative FDA approved…

Gain Therapeutics to Present at Public Ventures Discovery Day

2 years ago

Gain Therapeutics’ Former CEO and current Board Member Eric Richman to participate in fireside chat hosted by Public Ventures President…

Ibogaine By David Dardashti: Government Urged to Increase Funding for Quantum Electrodynamics Research

2 years ago

Exploring the Relationship Between Glial Cells and Electromagnetic Waves David Dardashti and Quantum Electrodynamic Ibogaine By David Dardashti supports quantum…